# Novel PSMA targeting alpha-emitting radioligand [211At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer

**Authors:** Lars Hvass, Marius Müller, Vladimir Shalgunov, Anne S. Clausen, Christian B. M. Poulie, Emma Aneheim, Holger J. Jensen, Matthias M. Herth, Andreas Kjaer

PMC · DOI: 10.1186/s13550-026-01378-z · EJNMMI Research · 2026-01-27

## Full-text entities

- **Genes:** FOLH1 (folate hydrolase 1) [NCBI Gene 2346] {aka FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM}
- **Diseases:** tumor (MESH:D009369), prostate cancer (MESH:D011471)
- **Chemicals:** 211At]PSAt-3-Ga (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917014/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917014/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917014/full.md

---
Source: https://tomesphere.com/paper/PMC12917014